These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2110437)

  • 1. Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833) for treatment of complicated urinary tract infections.
    Wolfhagen MJ; Hoepelman AI; Verhoef J
    Antimicrob Agents Chemother; 1990 Mar; 34(3):409-12. PubMed ID: 2110437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complicated urinary infection in spinal injury patients: fleroxacin compared with ciprofloxacin.
    Whitby M; Angus L; Nimmo G; Hill V
    Chemotherapy; 1996; 42(6):468-72. PubMed ID: 8957583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.
    Iravani A
    Am J Med; 1993 Mar; 94(3A):89S-96S. PubMed ID: 8452189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.
    Bowie WR; Willetts V; Jewesson PJ
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1778-82. PubMed ID: 2511802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on the treatment duration of an antibacterial agent in complicated urinary tract infections. Utility and recurrence after 14-day treatment by fleroxacin].
    Arakawa S; Takagi S; Matsumoto O; Kamidono S; Sengoku A; Hazama M; Yamazaki H; Hamami G; Okamoto Y; Tanaka H
    Jpn J Antibiot; 1991 Jul; 44(7):718-31. PubMed ID: 1909383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complicated urinary tract infections treated with extended-release ciprofloxacin with emphasis on Pseudomonas aeruginosa.
    Saltzstein D; Wachs B; Perroncel R; Benson A; Herrington J; Haverstock D; Pertel P
    J Chemother; 2007 Dec; 19(6):694-702. PubMed ID: 18230553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fleroxacin in single dose oral therapy of uncomplicated lower urinary tract infection.
    Kosmidis J; Gargalianos P; Adamis G; Petropoulou D; Makris D
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():219-21. PubMed ID: 3144541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC; Nenad RC; Iravani A; Tice AD; Mansfield DL; Magner DJ; Dorr MB; Talbot GH
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens.
    Richard GA; Mathew CP; Kirstein JM; Orchard D; Yang JY
    Urology; 2002 Mar; 59(3):334-9. PubMed ID: 11880065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
    Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue.
    Naber KG; Sörgel F; Kees F; Schumacher H; Metz R; Grobecker H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():199-207. PubMed ID: 2462556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
    Cox CE
    Am J Med; 1992 Apr; 92(4A):82S-86S. PubMed ID: 1316077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of fleroxacin (RO 23-6240) as single-oral-dose therapy of culture-proven chancroid in Nairobi, Kenya.
    MacDonald KS; Cameron DW; D'Costa L; Ndinya-Achola JO; Plummer FA; Ronald AR
    Antimicrob Agents Chemother; 1989 May; 33(5):612-4. PubMed ID: 2502065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
    Naber KG; Allin DM; Clarysse L; Haworth DA; James IG; Raini C; Schneider H; Wall A; Weitz P; Hopkins G; Ankel-Fuchs D
    Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis.
    Pust RA; Ackenheil-Köppe HR; Weidner W; Meier-Ewert H
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():227-30. PubMed ID: 3144543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection.
    Gelfand MS; Simmons BP; Craft RB; Grogan J; Amarshi N
    Am J Med; 1993 Mar; 94(3A):126S-130S. PubMed ID: 8452168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections.
    Mirone V; Fusco F; Taglialatela D; Verze P; Di Vito C; Lotti T; Imbimbo C;
    J Chemother; 2009 Dec; 21(6):651-60. PubMed ID: 20071289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
    Pisani E; Bartoletti R; Trinchieri A; Rizzo M
    J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection.
    Pittman W; Moon JO; Hamrick LC; Cox CE; Clark J; Childs S; Pizzuti D; Fredericks J; St Clair P
    Am J Med; 1993 Mar; 94(3A):101S-104S. PubMed ID: 8452163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.